awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26784482-FC675FA2-B5A8-498A-B93E-05BE049BBAE0
Q26784482-FC675FA2-B5A8-498A-B93E-05BE049BBAE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784482-FC675FA2-B5A8-498A-B93E-05BE049BBAE0
PCSK9 inhibition: the way forward in the treatment of dyslipidemia
P2860
Q26784482-FC675FA2-B5A8-498A-B93E-05BE049BBAE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784482-FC675FA2-B5A8-498A-B93E-05BE049BBAE0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
409ec086dddae5a2cb7743bcb110c903d411626b
P2860
Effects of extended-release niacin with laropiprant in high-risk patients.